Imipenemase-producing carbapenem-resistant Enterobacteriaceae transmission in a long-term-care facility during a community-wide multidrug resistant organism outbreak-North Carolina, 2017
- PMID: 31331713
- DOI: 10.1016/j.ajic.2019.05.022
Imipenemase-producing carbapenem-resistant Enterobacteriaceae transmission in a long-term-care facility during a community-wide multidrug resistant organism outbreak-North Carolina, 2017
Abstract
We describe an outbreak of imipenemase metallo-β-lactamase-producing organisms in a long-term-care facility (LTCF) amid a larger community outbreak of extended-spectrum β-lactamase-producing organisms. Transmission was propagated by inadequate infection prevention practices. We provided infection prevention recommendations and education, facilitated colonization screening, and increased interfacility communication. This outbreak demonstrates the unmet need for infection prevention education in long-term-care facilities and the importance of prompt public health response to ensure appropriate identification, containment, and prevention of emerging resistance.
Keywords: Antimicrobial resistance; Carbapenemase-producing carbapenem-resistant Enterobacteriaceae; Health care–associated; Infection prevention.
Published by Elsevier Inc.
Similar articles
-
Screening of nursing home residents for colonization with carbapenem-resistant Enterobacteriaceae admitted to acute care hospitals: Incidence and risk factors.Am J Infect Control. 2016 Feb;44(2):126-30. doi: 10.1016/j.ajic.2015.09.019. Epub 2015 Nov 26. Am J Infect Control. 2016. PMID: 26631643
-
Carbapenemase-Producing Enterobacteriaceae and Nonfermentative Bacteria, the Philippines, 2013-2016.Emerg Infect Dis. 2017 Sep;23(9):1597-1598. doi: 10.3201/eid2309.161237. Emerg Infect Dis. 2017. PMID: 28820383 Free PMC article.
-
Risk factors for fecal carriage of IMP-6-producing Enterobacteriaceae at a long-term care hospital in Japan: A follow-up report from the northern Osaka multicentre study group.J Infect Chemother. 2018 Sep;24(9):769-772. doi: 10.1016/j.jiac.2018.03.009. Epub 2018 Apr 12. J Infect Chemother. 2018. PMID: 29656900
-
Carbapenem-resistant Enterobacteriaceae: An emerging bacterial threat.Semin Diagn Pathol. 2019 May;36(3):182-186. doi: 10.1053/j.semdp.2019.04.011. Epub 2019 Apr 17. Semin Diagn Pathol. 2019. PMID: 31056277 Review.
-
The rapid spread of carbapenem-resistant Enterobacteriaceae.Drug Resist Updat. 2016 Nov;29:30-46. doi: 10.1016/j.drup.2016.09.002. Epub 2016 Sep 19. Drug Resist Updat. 2016. PMID: 27912842 Free PMC article. Review.
Cited by
-
Global Threat of Carbapenem-Resistant Gram-Negative Bacteria.Front Cell Infect Microbiol. 2022 Mar 15;12:823684. doi: 10.3389/fcimb.2022.823684. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35372099 Free PMC article. Review.
-
Carbapenemase production among less-common Enterobacterales genera: 10 US sites, 2018.JAC Antimicrob Resist. 2021 Sep 4;3(3):dlab137. doi: 10.1093/jacamr/dlab137. eCollection 2021 Sep. JAC Antimicrob Resist. 2021. PMID: 34514407 Free PMC article.
-
Carbapenem-Resistant Enterobacterales in Long-Term Care Facilities: A Global and Narrative Review.Front Cell Infect Microbiol. 2021 Apr 23;11:601968. doi: 10.3389/fcimb.2021.601968. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 33968793 Free PMC article. Review.
-
Ceftazidime-Avibactam Combination Therapy Compared to Ceftazidime-Avibactam Monotherapy for the Treatment of Severe Infections Due to Carbapenem-Resistant Pathogens: A Systematic Review and Network Meta-Analysis.Antibiotics (Basel). 2020 Jul 7;9(7):388. doi: 10.3390/antibiotics9070388. Antibiotics (Basel). 2020. PMID: 32645986 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
